• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novartis AG Common Stock (NY:NVS)

    120.77 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Jun 12, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,800
    Open 120.77
    Bid (Size) 119.70 (8)
    Ask (Size) 119.77 (8)
    Prev. Close 120.77
    Today's Range 120.77 - 120.77
    52wk Range 96.06 - 120.92
    Shares Outstanding N/A
    Dividend Yield 3.31%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
    Novartis' Fabhalta improved hemoglobin, reduced fatigue and eliminated transfusion need in a Phase 3B PNH study presented at the 2025 EHA Congress. 
    Via Benzinga
    PU Prime Broadens Portfolio with New Global Indices
    Via GlobePRwire
    Topics Derivatives Economy
    Exposures Derivatives Economy

    Performance

    YTD
    +24.3%
    +24.3%
    1 Month
    +13.0%
    +13.0%
    3 Month
    +10.7%
    +10.7%
    6 Month
    +22.5%
    +22.5%
    1 Year
    +14.4%
    +14.4%

    More News

    Read More
    2 Dividend Growth Stocks to Buy and Hold Forever
    Via The Motley Fool
    Topics Intellectual Property
    Exposures Intellectual Property
    Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position
    Via Stocktwits
    Topics ETFs
    Is Novartis Gaining or Losing Market Support?
    Via Benzinga
    Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019
    Via Benzinga
    Exposures Product Safety
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Global Billion Dollar Oncology Industry Experiencing Substantial Growth Driven by Increasing Cancer Incidences
    From FN Media Group LLC
    Via GlobeNewswire
    The Smartest Vanguard ETF to Buy With $500 Right Now
    Via The Motley Fool
    Topics ETFs
    Prediction: This "Magnificent Seven" Stock Will Be the Most Valuable Company in the World in 10 Years
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Lazard Transforms Mutual Fund Into IEQ ETF Amid Rising Demand For International Stocks
    Via Benzinga
    Topics ETFs
    Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030
    Via Benzinga
    Here's My Favorite High-Dividend ETF to Buy Right Now
    Via The Motley Fool
    Topics ETFs
    Trump’s ‘Most Favored Nation’ Drug Plan Likely To Face Pushback, JP Morgan Analysts Say
    Via Stocktwits
    Topics ETFs Government Stocks
    Exposures Political US Equities
    S&P 500, Dow Jones Pharma Stocks Boomerang As Trump Threatens Drug-Price Reform
    Via Investor's Business Daily
    Topics Government Stocks
    Exposures Political US Equities
    Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study
    Via Benzinga
    FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
    Via Benzinga
    Exposures Product Safety
    BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion
    Via Benzinga
    Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead
    Via Stocktwits
    Topics Stocks
    Exposures US Equities
    Humana Does Not Alter 2025 Outlook Despite Sales Miss And Medicare Membership Decline
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Novartis To Buy US Kidney Drug Developer Regulus Therapeutics For Around $800 Million
    Via Benzinga
    AppLovin Stock Tumbles After Edgewater Research Cuts Estimates Citing Rising Competition
    Via Stocktwits
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Regulus Therapeutics Stock Skyrockets On $1.7B Acquisition Offer From Novartis
    Via Stocktwits
    Novartis Q1 Earnings Beat Street View, CEO 'Confident' In Delivering Upgraded Guidance
    Via Benzinga
    Topics Earnings
    Exposures Financial

    Frequently Asked Questions

    Is Novartis AG Common Stock publicly traded?
    Yes, Novartis AG Common Stock is publicly traded.
    What exchange does Novartis AG Common Stock trade on?
    Novartis AG Common Stock trades on the New York Stock Exchange
    What is the ticker symbol for Novartis AG Common Stock?
    The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
    What is the current price of Novartis AG Common Stock?
    The current price of Novartis AG Common Stock is 120.77
    When was Novartis AG Common Stock last traded?
    The last trade of Novartis AG Common Stock was at 06/12/25 07:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.